Our study suggests that both miR-21 and the components of the TGF-β1-SMAD-ILK signaling pathway, to which it is targeted, are expressed differentially between ectopic endometrial lesions and eutopic endometrium in women with endometriosis. The gene discussed is TGFB1; the disease is endometriosis.